Migdal Insurance & Financial Holdings Ltd.

Insurance

Position in NVO — Novo Nordisk A S

CIK 1415912 Petach Tikva, L3

Position in NVO

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$133,273

+$31,108 QoQ

Shares Held

2,780

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,058

of 1,348 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Migdal Insurance & Financial Holdings Ltd. holds $442,034,203 across 9 Drug Manufacturers - General names. NVO ranks #7 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	562,561	$141,562,850
2	AZN	Astrazeneca PLC	676,000	$128,183,120
3	MRK	Merck & Co., Inc.	730,035	$93,809,497
4	GILD	Gilead Sciences, Inc.	604,000	$76,309,360
5	LLY	ELI LILLY & Co	1,328	$1,592,843
6	JNJ	Johnson & Johnson	1,580	$401,272
7	NVO	Novo Nordisk A S This page	2,780	$133,273
8	SNY	Sanofi	521	$22,225

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$133,273	2,780	0.0%	Shares	Defined	2026-08-10
2026-03-31	$102,165	2,780	0.0%	Shares	Defined	2026-05-14
2025-12-31	$141,446	2,780	0.0%	Shares	Defined	2026-01-28
2025-09-30	$154,262	2,780	0.0%	Shares	Defined	2025-10-30
2025-06-30	$191,875	2,780	-99.2%	Shares	Defined	2025-09-15
2025-03-31	$23,844,932	343,389	+9521.4%	Shares	Defined	2025-05-05
2024-12-31	$307,005	3,569	-33.5%	Shares	Defined	2025-01-28
2024-09-30	$639,286	5,369	-33.5%	Shares	Defined	2024-11-04
2024-06-30	$1,153,053	8,078	-2.2%	Shares	Defined	2024-07-29
2024-03-31	$1,060,712	8,261	-2.2%	Shares	Defined	2024-05-01
2023-12-31	$873,738	8,446	+18.2%	Shares	Defined	2024-01-31
2023-09-30	$649,857	7,146	—	Shares	Defined	2023-10-25
No filing history on record for this holder in this stock.